PDSB Market Cap History



Below is a table of the PDSB market cap history going back to 3/18/2019:

Date PDSB Market Cap
3/18/201950.27M
5/8/201934.95M
7/25/201929.77M
10/31/201917.45M
3/9/202015.74M
5/7/202013.36M
8/6/202059.30M
11/6/202052.98M
3/11/2021117.32M
5/7/2021107.83M
8/6/2021320.91M
11/3/2021349.75M
3/25/2022174.67M
8/1/2022118.39M
11/7/2022151.38M
3/21/2023193.25M
4/27/2023187.41M
5/8/2023207.75M
8/7/2023163.60M
11/7/2023146.36M

Also see: PDSB Shares Outstanding History
and PDSB YTD Return
PDSB Historical Market Cap:
+25.87% CAGR
PDSB Historical Market Cap: +25.87% CAGR

Mouse over chart for data details
3/18/2019 ...11/7/2023
PDS Biotechnology is an immunotherapy company developing molecularly targeted immunotherapies designed to overcome the limitations of existing immunotherapy and vaccine technologies. Co.'s T cell activating platforms designed to train the immune system to attack and destroy disease; Versamune®, and Versamune plus PDS0301 for treatments in oncology; and Infectimune, for treatments in infectious disease. Co. develops targeted product candidates to treat several cancers including Human Papillomavirus-associated cancers, melanoma, colorectal, lung, breast and prostate cancers. Co.'s infectious disease candidates are of potential interest for use in COVID-19 and universal influenza vaccines. We show 20 historical shares outstanding datapoints in our PDSB shares outstanding history coverage, used to compute PDSB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PDSB market cap history over the course of time is important for investors interested in comparing PDSB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PDSB versus a peer is one thing; comparing PDSB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PDSB can fluctuate over the course of history. With this page we aim to empower investors researching PDSB by allowing them to research the PDSB market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PDSB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
PDS Biotechnology (PDSB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PEN Market Cap History
PEPG Market Cap History
PETV Market Cap History
PETX Market Cap History
PFE Market Cap History
PGEN Market Cap History
PGNX Market Cap History
PGNY Market Cap History
PHAS Market Cap History
PHAT Market Cap History
More Healthcare companies »

 

PDSB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.